TITLE

Unravelling the hidden heterogeneities of diffuse large B-cell lymphoma based on coupled two-way clustering

PUB. DATE
January 2007
SOURCE
BMC Genomics;2007, Vol. 8, p332
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
43772194

 

Related Articles

  • AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles. Madan, Rashna; Gormley, Robert; Dulau, Alina; Dongsheng Xu; Walsh, Daniel; Ramesh, K. H.; Cannizaro, Linda; Tamas, Ecaterina F.; Kumar, Pankaj; Sparano, Joseph; LeValley, Aaron; Xiaonan Xue; Bhattacharyya, Pritish K.; Ioachim, Harry L.; Ratech, Howard; Xu, Dongsheng; Xue, Xiaonan // Modern Pathology;Mar2006, Vol. 19 Issue 3, p438 

    Based on gene expression profiling, diffuse large B-cell lymphomas arising in immunocompetent patients can be divided into germinal center and activated B-cell types. Since little is known about acquired immunodeficiency syndrome associated diffuse large B-cell lymphomas, we tested whether the...

  • Aberrant expression of CCR4 in diffuse large B-cell lymphoma, not otherwise specified. Nakayama, S; Yokote, T; Hirata, Y; Iwaki, K; Akioka, T; Miyoshi, T; Hiraoka, N; Takayama, A; Nishiwaki, U; Masuda, Y; Nishimura, Y; Tsuji, M; Hanafusa, T // Leukemia (08876924);Dec2013, Vol. 27 Issue 12, p2382 

    A letter to the editor is presented that discusses diffuse large b-cell lymphoma.

  • Clinical Prognostic Biomarkers in Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma. Chastain, Elizabeth C.; Duncavage, Eric J. // Archives of Pathology & Laboratory Medicine;May2015, Vol. 139 Issue 5, p602 

    Context.—Diffuse large B-cell lymphoma and chronic lymphocytic leukemia are 2 of the most common B-cell lymphomas in adults. Both diffuse large B-cell lymphoma and chronic lymphocytic leukemia share heterogeneous outcomes, and the use of prognostic biomarkers to better stratify risk in...

  • BY THE NUMBERS.  // Hem/Onc Today;8/10/2012, Vol. 13 Issue 15, p1 

    A chart is presented that revealed poorer outcomes of higher immunohistochemically-based double-hit score in diffuse large B-cell lymphoma.

  • Model-based clustering of array CGH data. Sohrab P. Shah; K-John Cheung; Nathalie A. Johnson; Guillaume Alain; Randy D. Gascoyne; Douglas E. Horsman; Raymond T. Ng; Kevin P. Murphy // Bioinformatics;Jun2009, Vol. 25 Issue 12, pi30 

    Motivation: Analysis of array comparative genomic hybridization (aCGH) data for recurrent DNA copy number alterations from a cohort of patients can yield distinct sets of molecular signatures or profiles. This can be due to the presence of heterogeneous cancer subtypes within a supposedly...

  • Molecular heterogeneity of diffuse large B-cell lymphoma. Gascoyne, Randy D. // Hematology Journal;2004 Supplement 3, Vol. 5, pS144 

    Studies the molecular genetic heterogeneity of diffuse large B-cell lymphoma. Disease initiative events;Loss of critical tumor suppressor genes; Gene copy number alterations; Gene expression profiles.

  • Therapy of non-Hodgkin's lymphoma. Coffey, J.; Hodgson, D. C.; Gospodarowicz, M. K. // European Journal of Nuclear Medicine & Molecular Imaging;2003 Supplement 1, Vol. 30 Issue 6, pS28 

    Non-Hodgkin's lymphomas are a heterogeneous group of malignancies of the lymphoid system. The exact etiology for most lymphomas has not been determined, but both viral and bacterial infections have been shown to be important etiologic factors. The WHO classification of hematopoietic and lymphoid...

  • Practical Applications in Immunohistochemistry. O’Malley, Dennis P.; Auerbach, Aaron; Weiss, Lawrence M. // Archives of Pathology & Laboratory Medicine;Sep2015, Vol. 139 Issue 9, p1094 

    Context.— Diffuse large B-cell lymphoma is the most commonly diagnosed subtype of lymphoma worldwide. The current World Health Organization (WHO) classification includes several subtypes, based on a combination of clinical, immunohistochemical, and genetic differences. Immunohistochemical...

  • Antineoplastics.  // Reactions Weekly;Jan2015, Vol. 1533 Issue 1, p53 

    An abstract of the article "How to treat B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma: Single centre experience," by J. Michalka and colleagues is presented.

  • Translocations affecting human immunoglobulin heavy chain locus. Sklyar, I. V.; Iarovaia, O. V.; Lipinski, M.; Vassetzky, Y. S. // Biopolymers & Cell;2014, Vol. 30 Issue 2, p90 

    Translocations involving human immunoglobulin heavy chain (IGH) locus are implicated in different leukaemias and lymphomas, including multiple myeloma, mantle cell lymphoma, Burkitt's lymphoma and diffuse large B cell lymphoma. We have analysed published data and identified eleven breakpoint...

Share

Other Topics